Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg - PubMed
Review
Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg
Gianluigi Tanda. Psychopharmacology (Berl). 2016 May.
Abstract
Rationale: The reinforcing effects of most abused drugs have been consistently demonstrated and studied in animal models, although those of marijuana were not, until the demonstration 15 years ago that delta-9-tetrahydrocannabinol (THC) could serve as a reinforcer in self-administration (SA) procedures in squirrel monkeys. Until then, those effects were inferred using indirect assessments.
Objectives: The aim of this manuscript is to review the primary preclinical procedures used to indirectly and directly infer reinforcing effects of cannabinoid drugs.
Methods: Results will be reviewed from studies of cannabinoid discrimination, intracranial self-stimulation (ICSS), conditioned place preference (CPP), as well as change in levels of dopamine assessed in brain areas related to reinforcement, and finally from self-administration procedures. For each procedure, an evaluation will be made of the predictive validity in detecting the potential abuse liability of cannabinoids based on seminal papers, with the addition of selected reports from more recent years especially those from Dr. Goldberg's research group.
Results and conclusions: ICSS and CPP do not provide consistent results for the assessment of potential for abuse of cannabinoids. However, drug discrimination and neurochemistry procedures appear to detect potential for abuse of cannabinoids, as well as several novel "designer cannabinoid drugs." Though after 15 years transfer of the self-administration model of marijuana abuse from squirrel monkeys to other species remains somewhat problematic, studies with the former species have substantially advanced the field, and several reports have been published with consistent self-administration of cannabinoid agonists in rodents.
Keywords: Addiction; Cannabis; Delta-9-THC; Dopamine neurochemistry; Drug discrimination; Marijuana substance use disorders; Place conditioning; Self-administration; Spice.
Conflict of interest statement
The author declares no conflict of interests.
Figures

Panel A shows that local intra VTA, but not intra-accumbens shell, injections of β-endorphins potentiate the discriminative effects of small doses of THC, measured by % increase in THC appropriate lever selection, in rats trained to discriminate the subjective effects of THC 3 mg/kg i.p. from THC-Vehicle i.p. Panels B and C show that administration of THC, 3 mg/kg i.p., but not its vehicle, stimulates β-endorphin levels in dialysates from the VTA but not significantly from the accumbens shell. Modified from Solinas et al 2004. See text and the original article for more details about experimental procedures and results.

Panel A shows effects of THC when conditioning sessions with THC were conducted 48 hours apart. Potential dysphoric effects of THC were hypothesized to reduce the likelihood of place preference at low THC doses (1 mg/kg i.p.). In Panel B with 96 hours between THC injections, there was a significant place preference at 1 mg/kg i.p., but also place aversion at higher doses. Modified from Lepore et al 1995. See text and the original article for more details about experimental procedures and results.

Top Panel. Schematic drawings showing the location of microdialysis probes in the nucleus accumbens shell or core in rats self-administering WIN55,212-2 (12.5 µg/kg/infusion). Bottom panel shows the time course of changes from basal DA levels in dialysates from the shell and core of the nucleus accumbens in rats during 4 weeks (12 sessions) of WIN55,212-2 self-administration. Modified from Lecca et al 2006. See text and the original article for more details about experimental procedures and results.

Top panels (A and B) show the location of THC site infusions in the anterior, intermediate or posterior shell, or in the core, and in the anterior, posterior, or dorsal to posterior VTA, or in the substantia nigra. Panels C and D show the number of self-infusions of THC into different accumbens (C) or midbrain (D) sites, earned by rats during consecutive sessions. Session number 4 was characterized by substitution of THC by its vehicle. Modified from Zangen et al, 2006. Please see text or the original article for more details about experimental procedures and results..
Similar articles
-
Tanda G, Goldberg SR. Tanda G, et al. Psychopharmacology (Berl). 2003 Sep;169(2):115-34. doi: 10.1007/s00213-003-1485-z. Epub 2003 Jun 24. Psychopharmacology (Berl). 2003. PMID: 12827346 Review.
-
Self-administration of cannabinoids by experimental animals and human marijuana smokers.
Justinova Z, Goldberg SR, Heishman SJ, Tanda G. Justinova Z, et al. Pharmacol Biochem Behav. 2005 Jun;81(2):285-99. doi: 10.1016/j.pbb.2005.01.026. Pharmacol Biochem Behav. 2005. PMID: 15932767 Free PMC article. Review.
-
Study of cannabinoid dependence in animals.
Maldonado R. Maldonado R. Pharmacol Ther. 2002 Aug;95(2):153-64. doi: 10.1016/s0163-7258(02)00254-1. Pharmacol Ther. 2002. PMID: 12182962 Review.
-
Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys.
John WS, Martin TJ, Nader MA. John WS, et al. Neuropsychopharmacology. 2017 Jun;42(7):1522-1530. doi: 10.1038/npp.2017.2. Epub 2017 Jan 6. Neuropsychopharmacology. 2017. PMID: 28059083 Free PMC article.
-
Old and new synthetic cannabinoids: lessons from animal models.
Zanda MT, Fattore L. Zanda MT, et al. Drug Metab Rev. 2018 Feb;50(1):54-64. doi: 10.1080/03602532.2018.1430824. Epub 2018 Jan 29. Drug Metab Rev. 2018. PMID: 29376443 Review.
Cited by
-
McMahon LR. McMahon LR. Drug Alcohol Depend. 2016 Aug 1;165:87-93. doi: 10.1016/j.drugalcdep.2016.05.016. Epub 2016 Jun 3. Drug Alcohol Depend. 2016. PMID: 27289270 Free PMC article.
-
Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm.
Mustafa MA, Poklis JL, Karin KN, Elmer JA, Porter JH, Parra V, Lu D, Schlosburg JE, Lichtman AH. Mustafa MA, et al. Cannabis Cannabinoid Res. 2024 Apr;9(2):581-590. doi: 10.1089/can.2022.0198. Epub 2023 Jan 19. Cannabis Cannabinoid Res. 2024. PMID: 36656312
-
Li X, Hempel BJ, Yang HJ, Han X, Bi GH, Gardner EL, Xi ZX. Li X, et al. Eur Neuropsychopharmacol. 2021 Feb;43:38-51. doi: 10.1016/j.euroneuro.2020.11.019. Epub 2020 Dec 15. Eur Neuropsychopharmacol. 2021. PMID: 33334652 Free PMC article.
-
Wenzel JM, Cheer JF. Wenzel JM, et al. Neuropsychopharmacology. 2018 Jan;43(1):103-115. doi: 10.1038/npp.2017.126. Epub 2017 Jun 27. Neuropsychopharmacology. 2018. PMID: 28653666 Free PMC article. Review.
-
Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH. Owens RA, et al. Neuropharmacology. 2017 Oct;125:80-86. doi: 10.1016/j.neuropharm.2017.06.032. Epub 2017 Jun 30. Neuropharmacology. 2017. PMID: 28673548 Free PMC article.
References
-
- Acquas E, Pisanu A, Marrocu P, Di Chiara G. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. European journal of pharmacology. 2000;401:179–185. - PubMed
-
- Acquas E, Tanda G, Di Chiara G. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2002;27:182–193. - PubMed
-
- Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev. 1986;38:21–43. - PubMed
-
- Alici T, Appel JB. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide. Pharmacol Biochem Behav. 2004;79:431–437. - PubMed
-
- Amit Z, Corcoran ME, Charness ME, Shizgal P. Intake of diazepam and hashish by alcohol preferring rats deprived of alcohol. Physiology & behavior. 1973;10:523–527. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources